Downstream Processing Featured Articles

  1. FDA Approves First Seasonal Influenza Vaccine Manufactured Using Cell Culture Technology 11/20/2012

    The U.S. Food and Drug Administration announced recently the approval of Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal cells, instead of fertilized chicken eggs. Flucelvax is approved to prevent seasonal influenza in people ages 18 years and older.

  2. Fragile X Makes Brain Cells Talk Too Much 2/20/2013

    The most common inherited form of mental retardation and autism, fragile X syndrome, turns some brain cells into chatterboxes, scientists at Washington University School of Medicine in St. Louis report. By Michael C. Purdy

  3. Revision Of The EU GMP Guide: EU Commission Publishes Proposals For Chapters 3, 5, 6 And 8 1/24/2013

    On 17 January 2013, the EU Commission published the drafts of 4 revised chapters of the EU GMP Guide. The publication had been expected for a long time now.

  4. COVID-19 Consortium: Competitive Collab On A Plasma-Derived Therapy 12/14/2020

    A host of global biopharma competitors are collaborating under the CoVIg-19 Plasma Alliance to secure enough convalescent plasma to produce an effective COVID-19 therapeutic at global scale. Takeda’s Dr. Thomas R. Kreil will present at the upcoming FDA/Xavier PharmaLink Conference.

  5. Thallion And LFB Terminate Shigamabs Collaboration 2/20/2013

    Thallion Pharmaceuticals Inc. (TSX-V: TLN) ("Thallion") and LFB Biotechnologies ("LFB") today announced that they have reached an agreement on the termination of their Development and Licensing Agreement related to Thallion's Shigamabs® program.

  6. Major Cancer Protein Amplifies Global Gene Expression, NIH Study Finds 9/27/2012

    Scientists may have discovered why a protein called MYC can provoke a variety of cancers. Like many proteins associated with cancer, MYC helps regulate cell growth.

  7. Thermo Fisher Scientific Introduces Next-Generation Benchtop LC-MS System At ASMS 2012 5/21/2012

    Thermo Fisher Scientific Inc., the world leader in serving science, recently announced the Thermo Scientific Exactive Plus system, the company’s latest benchtop liquid chromatography-mass spectrometry (LC-MS) system for high-throughput screening, identification and quantification of compounds in complex matrices.

  8. Newfound Gene May Help Bacteria Survive In Extreme Environments 7/25/2012

    In the days following the 2010 Deepwater Horizon oil spill, methane-eating bacteria bloomed in the Gulf of Mexico, feasting on the methane that gushed, along with oil, from the damaged well. The sudden influx of microbes was a scientific curiosity: Prior to the oil spill, scientists had observed relatively few signs of methane-eating microbes in the area. By Jennifer Chu, MIT

  9. Researchers Discover New Mutations Driving Malignant Melanoma 1/25/2013

    Two new mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what scientists call the "dark matter" of the cancer genome, where cancer-related mutations haven't been previously found.

  10. Standardized Extractables Testing Advances Single Use Adoption 6/3/2015

    The Standardized Extractables Testing Protocol For Single-Use Systems In Biomanufacturing written by BPOG members last year establishes a foundation from which to create a standardized approach to extractables testing. However, since its release, there have been some questions and discussions about how to effectively implement the protocol.